Evolve With Us

Entrepreneurship and innovation are the essence of achieving our goals as we work to integrate science and technology with our professional passion to combat disease together.

We believe that this strong combination of science and technology will contribute to transforming medical discoveries into the best in the world, Moreover, it will improve the success rate of research and development, and reform effective prevention and treatment methods for the most challenging diseases such as cancer.


In Sippar we believe in the Pharmaceutical CGMP Initiative for the 21st Century launched by the American Food and Drug Administration (FDA) in 2002 to promote the adoption of innovative technologies that bring flexible and seamless pharmaceutical manufacturing sectors.

The initiative aims to facilitate the transformation to manufacturing methods and processes that ensure the production of high-quality pharmaceutical products without a wide organizational supervision.

Significant progress has been made towards this goal while recent natural disasters and the COVID-19 pandemic revealed weaknesses in the supply chain and the continued modernization of pharmaceutical manufacturing.